Steven Cohen’s AstraZeneca AZN Stock Holding History

Steven Cohen’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.9M	Buy	20,550 +100	+0.5%	+$18.8K	﹤0.01%	1937
2026 Q1	$4.03M	Hold	20,450	–	–	0.01%	1853
2025 Q4	$3.76M	Buy	20,450 +6,800	+50%	+$1.19M	﹤0.01%	2040
2025 Q3	$2.09M	Hold	13,650	–	–	﹤0.01%	1426
2025 Q2	$1.91M	Buy	+13,650	New	+$1.91M	﹤0.01%	1327
2024 Q4	–	Sell	-75,000	Closed	-$11.7M	–	2080
2024 Q3	$11.7M	Buy	+75,000	New	+$12.1M	0.03%	593
2023 Q1	–	Sell	-14,100	Closed	-$1.91M	–	2231
2022 Q4	$1.91M	Buy	+14,100	New	+$1.77M	0.01%	940
2022 Q3	–	Sell	-3,600	Closed	-$476K	–	1403
2022 Q2	$476K	Buy	+3,600	New	+$472K	﹤0.01%	1196

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Steven Cohen's AZN Position: Q2 2026 in Review

Steven Cohen reduced its AstraZeneca (AZN) stake by 42% in Q2 2026, selling an estimated $98.3M and leaving 711,547 shares worth $135M. The position accounts for 0.15% of the portfolio, ranked #143.

Steven Cohen first reported a position in AZN in Q2 2014 and has held it in 37 quarters since. The position peaked at $264M in Q3 2022. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Steven Cohen held 711,547 shares of AstraZeneca worth $135M as of Q2 2026.
Steven Cohen sold 522,418 AstraZeneca shares in Q2 2026, an estimated $98.3M.
AstraZeneca made up 0.15% of Steven Cohen's portfolio in Q2 2026, its #143 holding.
Steven Cohen first reported a position in AstraZeneca in Q2 2014 and has held it in 37 quarters since.
Steven Cohen's AstraZeneca position peaked at $264M in Q3 2022.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.